| abstract |
The present invention relates to a composition for the prevention or treatment of cell aging-related diseases using helmotimus as an active ingredient, and more specifically, helmotimus is aging-induced fibroblasts, umbilical cord blood endothelial cells, renal tubule cells, and retinal pigment epithelial cells. It was confirmed that it exhibits the senomorphic effect of restoring the function and morphology of cells of the cell, and as it is confirmed that it exhibits an effect of improving tissue fibrosis induced by cell aging through the senomorphic effect, the zotarolimus The composition containing as an active ingredient may be provided as a composition for the treatment of cell aging-related diseases. |